SobriGuard: Clinically Proven Aid for Alcohol Cessation
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $7.16 | $214.89 (0%) | 🛒 Add to cart |
| 60 | $6.78 | $429.78 $406.68 (5%) | 🛒 Add to cart |
| 90 | $6.64
Best per pill | $644.67 $597.47 (7%) | 🛒 Add to cart |
Synonyms | |||
SobriGuard is a prescription medication specifically formulated to support individuals in reducing or stopping alcohol consumption. Developed through rigorous clinical research, it targets the neurochemical pathways associated with alcohol dependence. This treatment is intended for use as part of a comprehensive management plan that includes counseling and behavioral support. Always use under medical supervision to ensure safety and efficacy.
Features
- Active ingredient: Naltrexone Hydrochloride 50 mg
- Delayed-release formulation for sustained effect
- White, film-coated, oblong tablet with “SG” debossed
- Packaged in blister packs of 30 tablets
- Requires prescription and medical oversight
- Manufactured in FDA-approved facilities under GMP standards
Benefits
- Reduces alcohol cravings by blocking opioid receptors in the brain
- Helps decrease the pleasurable effects of alcohol, supporting abstinence
- Supports long-term recovery when combined with behavioral therapy
- Minimizes relapse risk in patients committed to treatment
- Contributes to improved liver function and overall health over time
- Enhances quality of life by facilitating sustained sobriety
Common use
SobriGuard is indicated for the management of alcohol dependence in adults who wish to reduce or cease alcohol intake. It is most effective when integrated into a broader therapeutic program that includes psychological support, such as cognitive-behavioral therapy or support groups. Typical users are individuals diagnosed with alcohol use disorder (AUD) who have struggled to maintain abstinence through willpower or counseling alone. It is not intended for use in occasional drinkers seeking to reduce casual consumption.
Dosage and direction
The recommended dosage is one 50 mg tablet taken orally once daily, with or without food. It is advisable to take the tablet at the same time each day to maintain consistent blood levels. Treatment should be initiated under medical supervision, often after a period of alcohol abstinence (usually 3–7 days) to avoid precipitating withdrawal symptoms. Dosage adjustments are not typically required, but a healthcare provider may modify the regimen based on individual tolerance and response. Treatment duration varies but often extends for 3–6 months or longer, as determined by a physician.
Precautions
Before using SobriGuard, inform your healthcare provider of any history of liver disease, kidney impairment, or depression. Regular liver function tests may be recommended during treatment. Use with caution in patients with coagulation disorders or those taking anticoagulants. Avoid abrupt discontinuation without medical advice. This medication may cause dizziness or drowsiness; refrain from driving or operating machinery until you know how it affects you. Alcohol consumption during treatment is strongly discouraged, as it may reduce efficacy and increase adverse effects.
Contraindications
SobriGuard is contraindicated in patients with acute hepatitis or liver failure, those taking opioid analgesics or undergoing opioid dependence treatment, and individuals with a hypersensitivity to naltrexone or any component of the formulation. It should not be used in patients experiencing acute opioid withdrawal. Concomitant use with disulfiram is not recommended due to increased risk of hepatotoxicity. Not for use in patients under 18 years of age.
Possible side effect
Common side effects may include nausea (15%), headache (12%), dizziness (10%), fatigue (8%), insomnia (7%), and anxiety (5%). Less frequently, patients may experience vomiting, decreased appetite, joint pain, or rash. In rare cases, hepatotoxicity, depression, or suicidal ideation may occur. Most side effects are mild to moderate and often diminish within the first few weeks of treatment. Report any persistent or severe symptoms to a healthcare provider promptly.
Drug interaction
SobriGuard may interact with opioid-containing medications (e.g., cough suppressants, analgesics), potentially reducing their efficacy or precipitating withdrawal. Concurrent use with hepatotoxic drugs (e.g., acetaminophen, certain antifungals) may increase liver injury risk. Caution is advised with CNS depressants like benzodiazepines or sedatives due to additive effects. Inform your doctor of all prescription, over-the-counter, and herbal products you are using.
Missed dose
If a dose is missed, take it as soon as remembered unless it is nearly time for the next dose. Do not double the dose to catch up. If multiple doses are missed, consult your healthcare provider before resuming, as adjustment may be needed. Consistent daily use is important for optimal effect.
Overdose
In case of suspected overdose (symptoms may include severe nausea, vomiting, dizziness, or lethargy), seek immediate medical attention or contact a poison control center. There is no specific antidote; treatment is supportive and symptomatic. Provide healthcare professionals with details of the medication and quantity ingested.
Storage
Store at room temperature (15–30°C or 59–86°F) in the original blister pack to protect from moisture and light. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Dispose of unused medication via a pharmacy take-back program; do not flush.
Disclaimer
SobriGuard is a prescription medication and should be used only under the direction of a qualified healthcare provider. This information is for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Individual results may vary. Always follow your physician’s instructions and report any adverse effects.
Reviews
“After years of struggling with alcohol, SobriGuard gave me the support I needed to regain control. The cravings diminished significantly within weeks.” – James L., 47 “As a clinician, I’ve seen notable improvements in patients who adhere to SobriGuard alongside therapy. It’s a valuable tool in addiction treatment.” – Dr. Elena Torres, MD “The side effects were manageable, and the structured approach helped me stay committed to sobriety.” – Maria K., 34 “This medication, combined with counseling, finally helped my husband achieve long-term recovery. Grateful for this option.” – Sarah P., family member